Literature DB >> 8323734

Epithelium-mesenchyme interconversion as example of epithelial plasticity.

B Boyer1, J P Thiery.   

Abstract

This review focuses on epithelium-mesenchymal transitions (EMT), defined as dynamic cell restructurations changing the epithelial state of differentiation into a mesenchymal phenotype. These transitions, known to occur during embryogenesis are also involved during some pathological events of adult life, such as wound repair and metastasis of cancer cells. Numerous studies of embryonic EMTs, found during some morphogenetic processes, have stressed the importance of intercellular and cell-matrix adhesive interactions as key elements regulating cell dissociation and acquisition of cell motility. On the other hand, in vitro studies indicate that growth factors, growth-factor related molecules and extracellular matrix components are involved in initiation of EMT. Therefore, the cellular targets of EMT-inducing molecules are likely to include molecules participating in cell adhesion systems.

Entities:  

Mesh:

Year:  1993        PMID: 8323734     DOI: 10.1111/j.1699-0463.1993.tb00109.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  33 in total

1.  Epicardial spindle orientation controls cell entry into the myocardium.

Authors:  Mingfu Wu; Christopher L Smith; James A Hall; Ivy Lee; Kate Luby-Phelps; Michelle D Tallquist
Journal:  Dev Cell       Date:  2010-07-20       Impact factor: 12.270

2.  Tumor microenvironmental signaling elicits epithelial-mesenchymal plasticity through cooperation with transforming genetic events.

Authors:  Damian J Junk; Rocky Cipriano; Benjamin L Bryson; Hannah L Gilmore; Mark W Jackson
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

3.  Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer.

Authors:  Yelena Mironchik; Paul T Winnard; Farhad Vesuna; Yoshinori Kato; Flonne Wildes; Arvind P Pathak; Scott Kominsky; Dmitri Artemov; Zaver Bhujwalla; Paul Van Diest; Horst Burger; Carlotta Glackin; Venu Raman
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

Review 4.  The cellular basis of metastasis.

Authors:  P Ruiz; U Günthert
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

5.  Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival.

Authors:  Mark J Schliekelman; Ayumu Taguchi; Jun Zhu; Xudong Dai; Jaime Rodriguez; Muge Celiktas; Qing Zhang; Alice Chin; Chee-Hong Wong; Hong Wang; Lisa McFerrin; Suhaida A Selamat; Chenchen Yang; Evan M Kroh; Kavita S Garg; Carmen Behrens; Adi F Gazdar; Ite A Laird-Offringa; Muneesh Tewari; Ignacio I Wistuba; Jean P Thiery; Samir M Hanash
Journal:  Cancer Res       Date:  2015-03-05       Impact factor: 12.701

Review 6.  Sheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transition.

Authors:  Jeffrey T Chang; Sendurai A Mani
Journal:  Cancer Lett       Date:  2013-03-14       Impact factor: 8.679

Review 7.  Inflammatory microenvironment contributes to epithelial-mesenchymal transition in gastric cancer.

Authors:  Hui-Ying Ma; Xin-Zhou Liu; Chun-Min Liang
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

Review 8.  Emerging role of tumor cell plasticity in modifying therapeutic response.

Authors:  Siyuan Qin; Jingwen Jiang; Yi Lu; Edouard C Nice; Canhua Huang; Jian Zhang; Weifeng He
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

9.  Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers.

Authors:  Sendurai A Mani; Jing Yang; Mary Brooks; Gunda Schwaninger; Alicia Zhou; Naoyuki Miura; Jeffery L Kutok; Kimberly Hartwell; Andrea L Richardson; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-30       Impact factor: 11.205

Review 10.  ZNF281/ZBP-99: a new player in epithelial-mesenchymal transition, stemness, and cancer.

Authors:  Stefanie Hahn; Heiko Hermeking
Journal:  J Mol Med (Berl)       Date:  2014-05-18       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.